CJC-1295 + Ipamorelin
CJC-1295 (no DAC) + Ipamorelin blend · 10mg per vial
| Compound | CJC-1295 + Ipamorelin |
| Family | Peptide Blends |
| CAS | 863288-34-0 / 170851-70-4 |
| Molecular formula | C165H269N47O46 / C38H49N9O5 |
| Molecular weight | 3647.2 / 711.8 Da |
| Residues | 30 / 5 amino acids |
| Appearance | White lyophilized powder |
| Solubility | Bacteriostatic water (preferred) · acetate buffer 0.05 M |
| Purity (HPLC) | Blend |
| Current lot | VTL-0421 |
For in-vitro research only. This compound is sold strictly for laboratory study. Not for human or veterinary use. Not a drug, supplement, food, or cosmetic. Acceptance of the Research-Use-Only Acknowledgement is required at checkout.
Handling is set by your laboratory SOP
Vitatide does not provide reconstitution, dosing, administration, or route-of-use protocols. Use posted lot documents where available and your laboratory's validated procedures.
Primary structure
30 / 5-residue peptide. Peptide Blends class.
Handling & storage
Storage conditions should be read from lot-specific COA/source documents where available, then handled under your laboratory's validated SOP.
Use the lot-specific COA or source document where available; otherwise follow your laboratory's validated storage SOP.
Vitatide does not provide preparation, administration, or use-window protocols; post-receipt handling is set by the end laboratory.
